Related Experiment Video
Updated: May 1, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?
Neeta D Gade1, Mohiuddin S Qazi1
1Department of Microbiology, Government Medical College, Nagpur, Maharashtra, India.
Fluoroquinolone resistance is high in Staphylococcus aureus, with ciprofloxacin ineffective against MRSA. Vancomycin remains the preferred treatment for MRSA infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Staphylococcus aureus is a significant human pathogen.
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a growing public health threat.
- Evaluating antimicrobial susceptibility is crucial for effective treatment.
Purpose of the Study:
- To assess the effectiveness of commonly used fluoroquinolones against Staphylococcus aureus isolates.
- To determine the prevalence of MRSA in clinical specimens.
- To identify optimal therapeutic agents for MRSA infections.
Main Methods:
- Susceptibility testing of 250 S. aureus isolates using Kirby-Bauer disc diffusion.
- MRSA detection via cefoxitin disk diffusion.
- Vancomycin Minimum Inhibitory Concentration (MIC) determination using E-test for MRSA strains.
- Phage typing of MRSA isolates.
Main Results:
- 42.8% of S. aureus isolates were identified as MRSA.
- High resistance rates to ciprofloxacin (92.5%) and ofloxacin (80.4%) were observed in MRSA.
- No resistance to vancomycin or linezolid was detected in any S. aureus isolates.
- Vancomycin MICs for MRSA ranged from 0.5 to 2 μg/ml.
Conclusions:
- Ciprofloxacin is no longer suitable for empirical treatment of MRSA infections.
- Fluoroquinolone use for MRSA should be guided by susceptibility testing.
- Vancomycin is the recommended treatment for MRSA infections.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management

